About
Technology
Issues
FAQ
Links
Official Page
INTACT (S/N1806) phase III randomized trial of concurrent chemoradiotherapy with or without atezolizumab in localized muscle-invasive bladder cancer: Safety update on first 73 patients.
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.